Novel investigational drugs active as single agents in multiple myeloma

D'Agostino, M; Salvini, M; Palumbo, A; Larocca, A; Gay, F

Gay, F (reprint author), Univ Citta Salute & Sci Torino, Univ Turin, Azienda Osped, Myeloma Unit,Div Hematol, Via Genova 3, I-10126 Turin, Italy.

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017; 26 (6): 699

Abstract

Introduction: Multiple myeloma (MM) is a hematologic malignancy characterized by proliferation of malignant plasma cells. patient outcome has improved......

Full Text Link